Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Ralph Boccia, MD, Michael A. Boxer, MD, Waleed Ghanima, MD PhD, Quentin A. Hill, Michelle Sholzberg, MDBSc,FRCPC,MSc, Michael D. Tarantino, MD, Yuliya Kreychman, PharmD, Robert P. Numerof, PhD, Brian Olender, BA, Leslie Todd, Sandy Tong, MD, Anne-Marie Duliege, MDMS, Nichola Cooper, MD MRCP, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1069.

https://doi.org/10.1182/blood-2019-126473

Published: 2019

Journal Articles

Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting

Leila Jafari, Jubair Hussain, Ravi Krishnadasan, MD, Keri R Maher, DO, Faiz Anwer, MD, Emad Elquza, MD MBA, Christopher Campen, PharmD, Lauren Sanders, PharmD, Alyssa Henglefelt, PharmD, Alicia Ortega, PharmD, Ali McBride, PharmD,MS

Blood (2019) 134 (Supplement_1): 2153.

https://doi.org/10.1182/blood-2019-132121

Published: 2019

Journal Articles

Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy

Nauman Saleem Siddiqui, MD, Andreas Klein, MD, Amandeep Godara, MD, Cindy Varga, MD BSc, Rachel J. Buchsbaum, MD, Michael C. Hughes, PhD

Blood (2019) 134 (Supplement_1): 3435.

https://doi.org/10.1182/blood-2019-128823

Published: 2019

Journal Articles

Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis

Neha Bhasin, MD, Denise Roe, DrPH, Janna M. Journeycake, MD, Chelsea Large, Kathylynn Saboda, MS, Beth Boulden Warren, MD MS, Marilyn J Manco-Johnson, MD, David T. Harris, PhD, Michael Badowski, PhD, Lynn Gerald, Vivian Moreno, Steven R. Lentz, MD PhD

Blood (2019) 134 (Supplement_1): 3650.

https://doi.org/10.1182/blood-2019-124858

Published: 2019

Journal Articles

Uncertainty in the R2 Calibration Curve for High Iron Concentration

John C Wood, MD PhD, Eamon Doyle, PhD, Nilesh Ghugre, PhD, Thomas Coates, MD

Blood (2019) 134 (Supplement_1): 3541.

https://doi.org/10.1182/blood-2019-128886

Published: 2019

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Kerry A. Rogers, MD, Michael A. Boxer, MD, Michael Y. Choi, MD, Richy Agajanian, MD, Donald M. Arnold, MD, Catherine M. Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Donna Chow, Robert P. Numerof, PhD, Hanzhe Zheng, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 3518.

https://doi.org/10.1182/blood-2019-126509

Published: 2019

Journal Articles

Final Results from the Multicenter, Open-Label, Phase II GIBB Study of Obinutuzumab+Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia

Jeff P. Sharman, MD, John M Burke, MD, Habte A Yimer, MD, Michael A. Boxer, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Alexey Danilov, MD PhD

Blood (2019) 134 (Supplement_1): 4317.

https://doi.org/10.1182/blood-2019-122482

Published: 2019

Journal Articles

Outcomes of Primary and Secondary Prophylaxis of Chemotherapy Induced and Febrile Neutropenia (CIN/FN) in Bendamustine Plus Rituximab (BR) Regimens in Patients with Lymphoma and Chronic Lymphocytic Leukemia (CLL): Real-World, Single-Center Experience

Logan Moore, Trace Bartels, BS, Daniel O. Persky, MD, Abhijeet Kumar, Ivo Abraham, PhD RN, Lauren Sanders, PharmD, Alicia Ortega, PharmD, Alyssa Henglefelt, PharmD, Ali McBride, PharmD,MS

Blood (2019) 134 (Supplement_1): 5353.

https://doi.org/10.1182/blood-2019-132148

Published: 2019

Journal Articles

Racial Differences in Nutritional Anemias: Analysis of Folate, Vitamin B12, and Iron Deficiencies

Miguel Gonzalez Velez, MD, Carolyn Mead-Harvey, MS, Heidi E. Kosiorek, MS, Yael Kusne, MD PhD, Leslie Padrnos, MD

Blood (2019) 134 (Supplement_1): 3387.

https://doi.org/10.1182/blood-2019-123791

Published: 2019

Journal Articles

Association of Clinical Epidemiologic Exposures and Overall Survival with Genome-Wide DNA Methylation Profiles in Acute Myeloid Leukemia: Analysis of the Mayo Clinic AML Epidemiology Cohort

César J. Torres-Gutierrez, BS, Michael G. Heckman, Ryan A. Hlady, Rhett P. Ketterling, Lisa Z. Sproat, Kathryn E. Pearce, Elizabeth R. Lesser, Nancy N. Diehl, Laura E. Finn, Liuyan Jennifer Jiang, Keith D. Robertson, James R. Cerhan, MD PhD, James M. Foran, MD

Blood (2018) 132 (Supplement 1): 3987.

https://doi.org/10.1182/blood-2018-99-119386

Published: 2018

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

Psychiatric Disturbance As a Presenting Symptom in Central Nervous Lymphoma

Akanksha Sharma, MD BSc, Natalie Ertz-Archambault, MD, Luke Mountjoy, DO, Alyx Porter, MD, Maciej M Mrugala, MD PhD MPH

Blood (2018) 132 (Supplement 1): 5415.

https://doi.org/10.1182/blood-2018-99-113690

Published: 2018

Journal Articles

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

James M. Foran, MD, Michael Heckman, MS, Rhett P. Ketterling, MD, Lisa Sproat, MD MSW, Liuyan Jennifer Jiang, MD, Bruce Eckloff, PhD, Nancy Diehl, Laura E. Finn, MD, Keith Robertson, PhD, Raoul Tibes, MD PhD, James R. Cerhan, MD PhD, Yan W Asmann, PhD

Blood (2017) 130 (Supplement 1): 570.

https://doi.org/10.1182/blood.V130.Suppl_1.570.570

Published: 2017

Journal Articles

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Sikander Ailawadhi, Abdel-Ghani Azzouqa, Zahara Meghji, Tania Jain, MD, Nancy Diehl, Stephanie P. Gebhardt, Vishal Shah, David O. Hodge, MS, Raj Patel, MD, Prachi Jani, MD, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Rafael Fonseca, MD

Blood (2017) 130 (Supplement 1): 5440.

https://doi.org/10.1182/blood.V130.Suppl_1.5440.5440

Published: 2017

Journal Articles

Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs

Diana Y Salas Coronado, MPA, Theresa Hahn, PhD, Randy Albelda, PhD, Nandita Khera, MD, Oreofe O. Odejide, MD, Robert J. Soiffer, MD, S. Yousuf Zafar, MD MHS, Gregory A. Abel, MD

Blood (2017) 130 (Supplement 1): 684.

https://doi.org/10.1182/blood.V130.Suppl_1.684.684

Published: 2017

Journal Articles

Racial Differences in Disease Characteristics: Understanding Multiple Myeloma in Hispanics

Tania Jain, MD, Rafael Fonseca, MD, Ruqin Chen, MD, Raj Patel, MD, Prachi Jani, MD, Veronica Gonzalez De La Calle, MD, Zahara Meghji, James E. Hoffman, MD, Alvaro J. Alencar, MD, Kevin R Kelly, MD PhD, Vivek Roy, MD, Taimur Sher, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2017) 130 (Supplement 1): 864.

https://doi.org/10.1182/blood.V130.Suppl_1.864.864

Published: 2017

Journal Articles

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Priyanka Pophali, MD, Allison C. Rosenthal, DO, Han Tun, MD, Craig B. Reeder, MD, Ivana N Micallef, MD, Luis Porrata, MD, Stephen M Ansell, MD PhD, Patrick Johnston, MD, David J Inwards, MD

Blood (2017) 130 (Supplement 1): 4536.

https://doi.org/10.1182/blood.V130.Suppl_1.4536.4536

Published: 2017

Journal Articles

Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis

Jeanne Palmer, MD, Tania Jain, MD, Katie L. Kunze, PhD, Daniel K. Partain, MD, Nandita Khera, MD, Lisa Sproat, MD MSW, Pierre Noel, MD, James L. Slack, MD, Vivek Roy, MD, Jose F. Leis, MD PhD, William J. Hogan, MBBCh, Ayalew Tefferi, MD, Veena D. S. Fauble, MD, Mrinal M. Patnaik, MDMBBS, Heidi Elizabeth Kosiorek, MS, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 4598.

https://doi.org/10.1182/blood.V130.Suppl_1.4598.4598

Published: 2017

Journal Articles

Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis

Tania Jain, MD, Katie L. Kunze, PhD, Daniel K. Partain, MD, Heidi Kosiorek, MS, Vivek Roy, MD, Nandita Khera, MD, James L. Slack, MD, Mrinal M. Patnaik, MDMBBS, William J. Hogan, MBBCh, Pierre Noel, MD, Veena D. S. Fauble, MD, Jose F. Leis, MD PhD, Lisa Sproat, MD MSW, Ruben A Mesa, MD, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 4561.

https://doi.org/10.1182/blood.V130.Suppl_1.4561.4561

Published: 2017

Journal Articles

Clinical Risk Factors Associated with Recurrent Venous Thromboembolism and Major Bleeding in Gastrointestinal Cancer Patients Receiving Doacs for Secondary Thromboprophylaxis

Alejandro Recio Boiles, MD, Jessica Vondrak, MD, Kristopher J. Abbate, AB, Hani M. Babiker, MD, Aaron J. Scott, MD, Ali McBride, PharmD, MS, BCPS, BCOP, Emad Elquza, MD MBA

Blood (2017) 130 (Supplement 1): 4918.

https://doi.org/10.1182/blood.V130.Suppl_1.4918.4918

Published: 2017

NARROW

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting

Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy

Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis

Uncertainty in the R2 Calibration Curve for High Iron Concentration

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Final Results from the Multicenter, Open-Label, Phase II GIBB Study of Obinutuzumab+Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia

Outcomes of Primary and Secondary Prophylaxis of Chemotherapy Induced and Febrile Neutropenia (CIN/FN) in Bendamustine Plus Rituximab (BR) Regimens in Patients with Lymphoma and Chronic Lymphocytic Leukemia (CLL): Real-World, Single-Center Experience

Racial Differences in Nutritional Anemias: Analysis of Folate, Vitamin B12, and Iron Deficiencies

Association of Clinical Epidemiologic Exposures and Overall Survival with Genome-Wide DNA Methylation Profiles in Acute Myeloid Leukemia: Analysis of the Mayo Clinic AML Epidemiology Cohort

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Psychiatric Disturbance As a Presenting Symptom in Central Nervous Lymphoma

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs

Racial Differences in Disease Characteristics: Understanding Multiple Myeloma in Hispanics

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis

Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis

Clinical Risk Factors Associated with Recurrent Venous Thromboembolism and Major Bleeding in Gastrointestinal Cancer Patients Receiving Doacs for Secondary Thromboprophylaxis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only